FDA: Preliminary Data Shows Possible Higher Death Risk From Paclitaxel Devices

Mealey's (March 20, 2019, 7:54 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on March 15 said a preliminary review of data has identified a potential “signal” of higher deaths among patients who were treated...
To view the full article, register now.